Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 16061 | HLA (HLA) | leukemia | NA | cyclophosphamide | NA | unclassified | |
| fifteen patients with aplastic anemia and 13 with acute leukemia were studied 36 to 1547 days after treatment with high-dose cyclophosphamide and/or total-body irradiation and marrow transplantation from hla identical siblings. | |||||||
| 16061 | HLA (HLA) | aplastic anemia | NA | cyclophosphamide | NA | unclassified | |
| fifteen patients with aplastic anemia and 13 with acute leukemia were studied 36 to 1547 days after treatment with high-dose cyclophosphamide and/or total-body irradiation and marrow transplantation from hla identical siblings. | |||||||
| 18618 | HLA (HLA) | transplantation | NA | NA | NA | unclassified | |
| transplantation of marrow from hla genotypically identical donors provided the highest six-month survival rate (63%) | |||||||
| 22306 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | NA | NA | unclassified | |
| four patients, treated for hematologic disorders with bone-marrow transplants from hla-identical siblings, spontaneously complained of dry eyes 8 to 12 months after transplantation. | |||||||
| 22306 | HLA IDENTICAL (HLA-IDENTICAL) | dry eyes | NA | NA | NA | unclassified | |
| four patients, treated for hematologic disorders with bone-marrow transplants from hla-identical siblings, spontaneously complained of dry eyes 8 to 12 months after transplantation. | |||||||
| 26718 | HLA (HLA) | transplantation | NA | NA | NA | only_studied | |
| the presence of cutaneous immunoglobulin and complement was investigated in 88 patients with and without graft-vs-host disease (gvhd) after transplantation of bone marrow from hla identical siblings for the treatment of acute leukemia or aplastic anemia. | |||||||
| 26718 | HLA (HLA) | leukemia | NA | NA | NA | only_studied | |
| the presence of cutaneous immunoglobulin and complement was investigated in 88 patients with and without graft-vs-host disease (gvhd) after transplantation of bone marrow from hla identical siblings for the treatment of acute leukemia or aplastic anemia. | |||||||
| 26718 | HLA (HLA) | aplastic anemia | NA | NA | NA | only_studied | |
| the presence of cutaneous immunoglobulin and complement was investigated in 88 patients with and without graft-vs-host disease (gvhd) after transplantation of bone marrow from hla identical siblings for the treatment of acute leukemia or aplastic anemia. | |||||||
| 26718 | HLA (HLA) | graft-vs-host disease | NA | NA | NA | only_studied | |
| the presence of cutaneous immunoglobulin and complement was investigated in 88 patients with and without graft-vs-host disease (gvhd) after transplantation of bone marrow from hla identical siblings for the treatment of acute leukemia or aplastic anemia. | |||||||
| 28425 | HLA COMPATIBLE (HLA-COMPATIBLE) | transplantation | NA | NA | NA | unclassified | |
| two patients treated with marrow transplants from hla-compatible donors currently are alive and free of leukemia with functioning grafts 13 and 38 months after transplantation. | |||||||
Copyright 2024